Parkinsonism in Ontario: Physician utilization

Canadian Journal of Neurological Sciences

Volumn 29, Issue 3, 2002, Pages 221-226

  Guttman, Mark ^a   Slaughter, P M ^a   Theriault, M E ^a   DeBoer, D P ^a   Naylor, C D ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE;

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; COST; HUMAN; MAJOR CLINICAL STUDY; PARKINSONISM; PHYSICIAN; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; COHORT STUDIES; FAMILY PRACTICE; HEALTH CARE COSTS; HUMANS; INTERNAL MEDICINE; LIKELIHOOD FUNCTIONS; NEUROLOGY; OFFICE VISITS; ONTARIO; PARKINSON DISEASE; PHYSICIANS; REFERRAL AND CONSULTATION; UNIVERSAL COVERAGE; UTILIZATION REVIEW;

EID: 0036687976     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100001980     Document Type: Article

References (6)

1. Practice parameter: Initiation of treatment for Parkinson's disease: An evidence based review
2. Parkinsonism in Ontario: Increased mortality compared to controls in a large cohort study
3. Parkinson's disease: First of two parts
4. Parkinson's disease: Second of two parts
5. A summary of studies on the quality of healthcare administrative databases in Canada
6. Technical appendix